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SUMMARY 
 
The occurrence of neurodegenerative disorders such as dementia has 
risen by unprecedented levels in part due to increases in average lifespan, 
thus engendering high socio-economic costs. Alzheimer’s Disease (AD) 
is the most common type of dementia and represents a central health 
problem in Western society, recognized mainly as a cognitive disorder 
where memory functions are primarily affected in the early stages of the 
disease. Diagnosis of AD has to be made mainly by the assessment of 
clinical features. Lately, emphasis is placed more and more on early 
diagnosis and detection of cognitive decline and related symptoms so that 
patients can benefit sufficiently from effective treatment and access to 
information, advice and support. At the same time, clinical assessments 
of cognitive and functional changes in AD have traditionally relied on 
cognitive neuropsychological screening tests, which can be biased by the 
clinician’s subjectivity and are not always sensitive to the earliest 
disease-related changes. In addition, the role of biomarkers has received 
increasing interest as early markers for AD, but involve invasive (eg, 
lumbar puncture), time-consuming (neuropsychological assessment) or 
expensive (PET) hospital-based procedures. Detecting early changes 
before clinical AD symptoms develop is crucial for the development and 
eventual success of therapeutic interventions.  Better measures for 
cognitive, functional and behavioral changes are therefore needed in the 
early stages of the disease. Assessment methods involving simple, non-
invasive and more accessible cost-effective tools are greatly required. For 
these reasons, information and communication technology (ICT), such as 
movement sensors and imaging and video processing, could be of interest 
because they enable the patients’ performances and actions to be captured 
objectively, in real time, and in real life situations. The use of these types 
of ICT may allow early identification of subjects in preclinical stages of 
AD as well as monitoring of the disease’s progression and treatment 
effects over time. 
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The general aim of this thesis was to investigate the potential 
contribution of ICT use for clinical assessment of cognitive, 
behavioral and functional changes in patients with AD and related 
disorders. In particular, focus was on the early stages of cognitive 
decline in order to allow earlier access to preventative intervention 
such as tailored cognitive and physical training through serious games. 
For this purpose, the use of different sensors including actigraphy, 
video analyses and speech analyses, were investigated in clinical 
practice. 
 
The thesis consists of three parts: first a review of ICT use for the 
specific case of apathy assessment and recommendations for ICT use 
for clinical assessment. In part II, different sensor-based studies are 
presented followed by part III, addressing the conclusion to consider 
the use of ICT within clinical trials for endpoint measures and follow-
up. Finally, proposed recommendations are presented for the use of 
ICT-based Serious Games as a potential early intervention tool for 
patients. 
 
In Chapter 2, an overview was given of current assessment 
tools for apathy in clinical practice and new approaches to assessment 
methods with the help ICT for which with a narrative literature review 
was conducted. The results suggest that there is evidence that apart 
from the currently used assessment methods for apathy, new ICT 
approaches could provide clinicians with valuable additional 
information for an earlier detection and therefore more accurate 
diagnosis of apathy. However, there are no ICT techniques 
specifically designed for the assessment of apathy, but nevertheless 
several techniques seem to be promising and deserve more study.  
 
In Chapter 3, basic recommendations have been provided 
concerning the development and the use of ICT for AD and related 
disorders. During an ICT and Mental Health workshop an expert panel 
consisting of clinicians (geriatrician, neurologist, psychiatrist, 
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psychologist), ICT engineers, representatives from the industry and 
patient association, was set up to prepare the first recommendations 
for the use of ICT in dementia research. The recommendations were 
divided into three sections corresponding to 1) clinical targets of 
interest for the use of ICT, 2) the conditions, the type of sensors and 
the outputs (scores) that could be used and obtained, 3) finally the last 
section concerns specifically the use of ICT within clinical trials. 
 
In Chapter 4, we assessed motor activity in Mild Cognitive 
Impairment (MCI) and healthy control subjects (HC) carrying out 
short functional activity tasks using ambulatory actigraphy. Secondly, 
the influence of depressive symptoms on motor activity was 
investigated. We found that MCI subjects had significantly reduced 
mean motor activity while carrying out directed and semi-directed 
activities, compared to healthy control subjects. However, no 
difference was found in motor activity between MCI subjects with or 
without depression. Together, these results indicate that actigraphic 
measurement of motor activity during the evaluation of instrumental 
activities of daily living (IADL) and motor tasks is a potential 
objective tool in detecting early changes in MCI. Depressive 
symptoms seem not to be associated with motor activity in MCI 
subjects. 
 
 In Chapter 5, we investigated the use of a video monitoring 
system for automatic event recognition for the assessment of IADL in 
19 healthy subjects and 19 MCI patients who had to carry out a 
standardized scenario consisting of several IADLs such as making a 
phone call while they were recorded by 2D video cameras. After the 
recording session, data was processed by a platform of video signal 
analysis in order to extract kinematic parameters detecting activities 
undertaken by the participant. We compared our automated activity 
quality prediction as well as cognitive health prediction with direct 
observation annotation and neuropsychological assessment scores. 
With a sensitivity of 85.31% and a precision of 75.90%, the overall 
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activities were correctly automatically detected. Activity frequency 
differed significantly between MCI and HC participants (p < 0.05). In 
all activities, differences in the execution time could be identified in 
the manually and automatically extracted data. We obtained 
statistically significant correlations between manually as automatically 
extracted parameters and neuropsychological test scores (p < 0.05). 
However, no significant differences were found between the groups 
according to the IADL scale. The results suggest that it is possible to 
assess IADL functioning with the help of an automatic video 
monitoring system and that even based on the extracted data, 
significant group differences can be obtained. 
  
In Chapter 6, we investigated the quantitative assessment of 
autonomy in dementia patients based not only on gait analysis but also on 
the participant performance on IADL automatically recognized by a 
video event monitoring system (EMS). Three groups of participants 
(healthy controls, MCI, and AD patients) had to carry out a standardized 
scenario consisting of physical tasks (single and dual task) and several 
IADL such as preparing a pillbox or making a phone call while being 
recorded. Video sensor data were processed by an EMS that 
automatically extracts kinematic parameters of the participants’ gait and 
recognizes their carried out activities. These parameters were then used 
for the assessment of the participants’ performance levels, here referred 
as autonomy. Autonomy assessment was approached as classification 
task using artificial intelligence methods that takes as input the 
parameters extracted by the EMS, here referred as behavioral profile. 
Activities were accurately recognized by the EMS with high precision. 
The most accurately recognized activities were “prepare medication” 
with 93% and “using phone” with 89% precision. The diagnostic group 
classifier obtained a precision of 73.46% when combining the analyses of 
physical tasks with IADL.  
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In a further analysis, the created autonomy group classifier 
obtained a precision of 83.67% when combining physical tasks and 
IADL. Results suggest that it is possible to quantitatively assess IADL 
functioning supported by an EMS and that even based on the extracted 
data the groups could be classified with high accuracy.  
 
 In Chapter 7, we evaluated the interest of using automatic 
speech analyses for the assessment of MCI and early-stage AD. For 
this, HC subjects and patients with MCI or AD were recorded while 
performing several short cognitive vocal tasks. The voice recordings 
were processed, and the first vocal markers were extracted using 
speech signal processing techniques. Second, the vocal markers were 
tested to assess their “power” to distinguish among HC, MCI, and AD. 
The second step included training automatic classifiers for detecting 
MCI and AD, using machine learning methods and testing the 
detection accuracy. We obtained classification accuracy of automatic 
audio analyses as follows: between HCs and those with MCI, 79%, 
between HCs and those with AD, 87% and between those with MCI 
and those with AD, 80%, demonstrating its assessment utility. Thus, 
automatic speech analyses could be an additional objective assessment 
tool for elderly with cognitive decline. 
 
 In Chapter 8, an opinion paper was presented suggesting that 
new ICT - such as automated speech and video analysis techniques 
and wearable accelerometers – may be successfully employed in 
clinical trials to improve the functional and cognitive assessment of 
these patients, thus contributing to an earlier AD diagnosis and 
providing additional ecological and objective end-point 
measurements.       
 
 In Chapter 9, we systematically analyzed the Strengths, 
Weaknesses, Opportunities, and Threats (SWOT) of employing 
Serious Games (SG) with patients with Alzheimer’s disease and other 
related disorders (ADRD) in order to provide practical 
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recommendations for the development and use of SG in these 
populations. These analyses and recommendations were gathered, 
commented on and validated during a 2-round workshop in the context 
of the 2013 Clinical Trial of Alzheimer’s Disease (CTAD) conference, 
and endorsed by stakeholders in the field. The results revealed that SG 
may offer very useful tools for professionals involved in the care of 
patients suffering from ADRD. However, more interdisciplinary work 
should be done in order to create SG specifically targeting these 
populations. Furthermore, in order to acquire more academic and 
professional credibility and acceptance, it will be necessary to invest 
more in research targeting efficacy and feasibility. Finally, the 
emerging ethical challenges should be considered a priority. 
 
 In Chapter 10, we provided a general discussion of our 
findings; its implications for clinical practice and AD trials, 
recommendations for future use of ICT, methodological 
considerations and recommendations for future research. Furthermore, 
the last chapter includes a summary of the findings, a description of 
knowledge valorisation, a list of author affiliations, list of 
publications, information about the author and acknowledgements.  
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